Riskpilot← Back to searchSign inGet full accessULSTEIN LEGESENTER AS
ASActiveOrg 966951214Sjøgata 3, 6065 UlsteinvikGeneral medical practice activities · NACE 8621Est. 199310 employees
Revenue 2024
NOK 16,2M
+11% vs 2023
EBITDA margin
24.0%
+10% vs 2023
Equity ratio
2.4%
Financial strength
Net profit 2024
NOK 3M
+13% vs 2023
| Revenue | NOK 16,2M | +11% |
| EBITDA | NOK 3,9M | +10% |
| Net profit | NOK 3M | +13% |
| Total assets | NOK 5,7M | +1% |
| Equity | NOK 136K | +16% |
| Employees | 10 | — |
Legal name
ULSTEIN LEGESENTER AS
Org number
966951214
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
1. februar 1993
Share capital
NOK 100 000
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Sjøgata 3, 6065 Ulsteinvik
Phone
+4770018989
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 316 | 13 369 | 13 739 | 14 535 | 16 201 |
| Staff expenses | −5 261 | −5 793 | −6 179 | −6 293 | −6 835 |
| EBITDA | 2 884 | 3 471 | 3 298 | 3 517 | 3 883 |
| Depreciation & amort. | −619 | −482 | −139 | −126 | −168 |
| EBIT | 2 265 | 2 989 | 3 158 | 3 391 | 3 714 |
| Net financials | −49 | −34 | −32 | −27 | 109 |
| Profit before tax | 2 216 | 2 955 | 3 126 | 3 364 | 3 823 |
| Tax | 488 | 651 | 689 | 741 | 854 |
| Net profit | 1 728 | 2 304 | 2 437 | 2 622 | 2 969 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 906 | 5 379 | 5 639 | 5 592 | 5 669 |
| Equity | 178 | 233 | 195 | 117 | 136 |
| Long-term debt | 993 | 739 | 481 | 227 | 0 |
| Short-term debt | 3 734 | 4 407 | 4 963 | 5 247 | 5 532 |
| Total debt | 4 727 | 5 146 | 5 444 | 5 474 | 5 532 |
EBITDA margin
24.0%
This company
15.8%
Market median
+52% vs market
20202024
Equity ratio
2.4%
This company
38.2%
Market median
-94% vs market
20202024
Return on equity
2176.6%
This company
18.4%
Market median
+11729% vs market
20202024
Net profit margin
18.3%
This company
8.1%
Market median
+126% vs market
20202024
Asset turnover
2.86×
This company
1.12×
Market median
+155% vs market
20202024
Debt / equity
40.56×
This company
0.62×
Market median
-6442% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2021 – 2025 | |
| Board of Directors | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 11.1% | 11.1% | 2022 | |
| Individual | 11.1% | 11.1% | 2022 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ULSTEIN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karsten Nesset Melø | Board of Directors | 0 companies |
| Karsten Melø | Board of Directors | 0 companies |
| Turid Krogstad Hanssen Grimstad | Board of Directors | 0 companies |